Clover Health, Mass. General, and ACP Decisions Research Team Secures Grant from National Institute of Health for Innovative ...
March 04 2021 - 4:05PM
Today, Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover”),
an innovative technology company improving health outcomes for
America's seniors, announced it is part of a team that received a
five-year grant from the National Institutes of Health (NIH) to
conduct a clinical study with researchers from Massachusetts
General Hospital, Harvard Medical School and ACP Decisions, a
non-profit foundation focused on advanced care planning. The study
focuses on the effectiveness of multimedia tools for improving
advance care planning among patients with life-limiting illness
receiving home-based primary care.
The number of patients living with serious chronic
illness and receiving home-based care through house call providers
is increasing. Often, these patients lack exposure to specialty
palliative care and receive education and counseling on advance
care planning much too late. Healthcare systems are seeking
scalable solutions that provide advance care planning services to
more patients earlier in their disease course yet are constrained
by the scarcity of palliative care clinicians and the lack of
clinical programs outside the hospital setting.
The goal of the study is to understand the
effectiveness of using video-based advance care planning resources
to optimize serious illness medical care for patients with chronic,
life-limiting illnesses receiving home-based care. The innovative
approach will incorporate predictive analytics and video technology
to significantly expand access to advance care planning for a
highly vulnerable population of patients.
The team assembled to conduct the study is one of
the leading research groups in palliative and serious illness
medical care, and this project has the potential to dramatically
improve the care of patients in home settings across the country
while simultaneously reducing the cost of care. Areej El-Jawahri,
an oncologist interested in improving patient decision-making based
at Massachusetts General Hospital (MGH) in Boston, and Angelo
Volandes, co-founder of the non-profit ACP Decisions and also
faculty at MGH are co-principal investigators. Co-Investigators
include: Kumar Dharmarajan, Chief Scientific Officer at Clover
Health and Assistant Professor Adjunct at the Yale School of
Medicine, who leads Clover’s clinical programs and R&D
initiatives for its most medically complex members; and, Aretha
Delight Davis, MD, JD, CEO of ACP Decisions, who leads
implementation projects for the nonprofit.
“Our goal at Clover is to improve the lives of
Medicare beneficiaries. We expect this study will generate pivotal
data to help us understand if scalable video technology can
meaningfully improve end of life outcomes for the most vulnerable
older adults who are rarely part of clinical trials,” said Kumar
Dharmarajan.
“This project has the potential to shift the
paradigm of care for seriously ill patients by utilizing technology
to inform their preferences for care and enhance patient-centered
decision-making at the end of life,” said Areej El-Jawahri.
“ACP Decisions’ mission is to empower patients and
their families so that they can remain in control of and in the
center of their care. We are excited to have the opportunity to
implement video decision aids on a large scale,” said Aretha
Delight Davis.
The research team will conduct a randomized
clinical trial of the video intervention versus normal care in 500
patients with life-limiting illness and a prognosis of one year or
less, receiving home-based care. The study will assess the
effectiveness of the intervention for patient preferences around
medical care, documentation of preferences, and hospice
utilization, as well as its ability to drive cost reductions.
The project will be conducted with the support of
the Clover Health In-Home Primary Care program, which has the
resources, infrastructure, and electronic health record
capabilities to ensure the success of this trial. Patients will be
recruited from 17 counties in New Jersey with substantial ethnic
and racial diversity.
To learn more about the study, visit
ClinicalTrials.gov.
About Clover Health Clover Health
is a healthcare technology company with a deeply rooted mission of
helping its members live their healthiest lives. Clover uses its
proprietary technology platform to collect, structure, and analyze
health and behavioral data to improve medical outcomes and lower
costs for patients. As a company whose business goals fully align
with its members' health needs, Clover works with members and their
doctors to become a valued partner. This trust is built by
proactively identifying at-risk individuals and teaming up with
physicians to accelerate care coordination and simultaneously
improve health outcomes and reduce avoidable costs. Clover has
offices in San Francisco, Jersey City, Nashville, and Hong Kong.
For more information, visit www.CloverHealth.com.
About the Massachusetts General
Hospital Massachusetts General Hospital, founded in 1811,
is the original and largest teaching hospital of Harvard Medical
School. The Mass General Research Institute conducts the largest
hospital-based research program in the nation, with annual research
operations of more than $1 billion and comprises more than 9,500
researchers working across more than 30 institutes, centers and
departments. In August 2019, Mass General was named #2 in the U.S.
News & World Report list of "America’s Best Hospitals."
About ACP Decisions
ACP Decisions (www.acpdecisions.org) is a
non-profit whose mission is to help patients and their families
engage in shared decision making with their health care team and to
empower them to make informed medical decisions. ACP Decisions uses
video support tools to empower patients, families, and healthcare
providers so that they can have patient/family-centered and
values-based advance care planning conversations.
Media Contact:
Andrew Still-Baxterpress@cloverhealth.com
Clover Health Investments (NASDAQ:CLOVW)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clover Health Investments (NASDAQ:CLOVW)
Historical Stock Chart
From Sep 2023 to Sep 2024